Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Lymphoma

  Free Subscription


29.01.2024

1 Am J Hematol
1 BMC Cancer
2 Bone Marrow Transplant
3 Br J Haematol
1 Discov Oncol
1 Haematologica
1 J Natl Cancer Inst
1 Lab Invest
4 Leuk Lymphoma
1 Mod Pathol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. WILSON MR, Kirkwood AA, Wong Doo N, Soussain C, et al
    Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.
    Am J Hematol. 2024;99:E46-E50.
    PubMed        


    BMC Cancer

  2. QIN Y, Song Y, Wang D, Bai O, et al
    Long-term outcomes with HLX01 (HanliKang((R))), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
    BMC Cancer. 2024;24:124.
    PubMed         Abstract available


    Bone Marrow Transplant

  3. DE PHILIPPIS C, Zucchinetti C, Mannina D, Krampera M, et al
    Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2024 Jan 25. doi: 10.1038/s41409-024-02205.
    PubMed        

  4. CHEN W, Shi J, Luo Y, Yu J, et al
    Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma.
    Bone Marrow Transplant. 2024 Jan 23. doi: 10.1038/s41409-023-02191.
    PubMed        


    Br J Haematol

  5. YANG P, Cai M, Cao Y, Fan S, et al
    Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis.
    Br J Haematol. 2024 Jan 25. doi: 10.1111/bjh.19317.
    PubMed         Abstract available

  6. ABEYAKOON C, Gregory GP
    New standards of care for treatment of diffuse large B-cell lymphoma.
    Br J Haematol. 2024 Jan 22. doi: 10.1111/bjh.19295.
    PubMed         Abstract available

  7. FOX CP, Chaganti S, McIlroy G, Barrington SF, et al
    The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline.
    Br J Haematol. 2024 Jan 21. doi: 10.1111/bjh.19273.
    PubMed        


    Discov Oncol

  8. KUMAR N, Kumar S, Shukla A, Kumar S, et al
    Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2'-deoxy-2'-b-fluoro-4'-azidocytidine)-induced inhibition of Dalton's lymphoma growth and proliferation.
    Discov Oncol. 2024;15:16.
    PubMed         Abstract available


    Haematologica

  9. DESMARES A, Bouzy S, Thonier F, Goustille J, et al
    Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a distinct genomic profile from that of gamma-delta T-cell large granular lymphocytic leukemia.
    Haematologica. 2024 Jan 25. doi: 10.3324/haematol.2023.283856.
    PubMed         Abstract available


    J Natl Cancer Inst

  10. WYATT KD, Birz S, Castellino SM, Henderson TO, et al
    Accelerating pediatric hodgkin lymphoma research: the hodgkin lymphoma data collaboration (NODAL).
    J Natl Cancer Inst. 2024 Jan 25:djae013. doi: 10.1093.
    PubMed         Abstract available


    Lab Invest

  11. SCHEIJDE-VERMEULEN MA, Kester LA, Westera L, Tops BBJ, et al
    Integration of RNA Sequencing, Whole Exome Sequencing, and Flow Cytometry Into Routine Diagnostic Workup of Pediatric Lymphomas.
    Lab Invest. 2024;104:100267.
    PubMed         Abstract available


    Leuk Lymphoma

  12. ARYA S, Mozessohn L, Gong I, Faught N, et al
    The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study.
    Leuk Lymphoma. 2024 Jan 24:1-9. doi: 10.1080/10428194.2024.2306463.
    PubMed         Abstract available

  13. GRIEVE C, Joseph A, Drullinsky P, Zelenetz AD, et al
    Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma.
    Leuk Lymphoma. 2024;65:235-241.
    PubMed         Abstract available

  14. LIONEL AC, Gurumurthi A, Fetooh A, Eldaya R, et al
    Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
    Leuk Lymphoma. 2024 Jan 22:1-5. doi: 10.1080/10428194.2024.2304622.
    PubMed        

  15. SOSNIA O, Pruszczyk K, Danecki M, Wasik-Szczepanek E, et al
    Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study Group.
    Leuk Lymphoma. 2023 Nov 3:1-12. doi: 10.1080/10428194.2023.2277140.
    PubMed         Abstract available


    Mod Pathol

  16. KALINOVA M, Mrhalova M, Kabickova E, Svaton M, et al
    Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling.
    Mod Pathol. 2024 Jan 22:100428. doi: 10.1016/j.modpat.2024.100428.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.